TRD205 for chronic pain after surgery
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests a new tablet called TRD205 for people who have had long-lasting nerve pain after surgery (at least 3 months). The goal is to see if it can reduce pain safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have had pain for at least 3 months after a surgery (such as thyroid, breast, orthopedic, or chest surgery).
- Your pain is in the area of surgery or along related nerve pathways.
- Your pain is nerve-related (diagnosed as neuropathic) and moderate to severe (at least 4 on a 0–10 pain scale).
- You are willing to use birth control and not donate sperm or eggs during the study and for 1 month after the last dose.
- You do not have other major causes of pain, serious health conditions, or recent cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new tablet called TRD205 for pain relief after bunion surgery on one foot. The tablet is given after surgery to see if it helps with pain while you recover.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This trial tests a new oral medication called TRD205 to relieve pain after a hip replacement. It aims to see how safe and effective it is compared to standard care, and you would take it within 48 hours after your operation.
This trial tests a new medication called HRS-2129 for managing pain after abdominal surgery. It is for adults who will have moderate to severe pain after their operation, and aims to see if the drug can help control that pain safely.
This trial tests an investigational tablet called HL-1186 for controlling pain after orthopedic surgery. It explores whether the drug can safely reduce moderate to severe pain when given after the procedure.
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
Hear when a new Chronic Postoperative Neuralgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.